Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mifepristone and ovarian function

T E Curry1, W B Nothnick

  • 1University of Kentucky, Lexington 40536, USA.

Clinical Obstetrics and Gynecology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortisol/glucocorticoid receptor: a critical mediator of the ovulatory process and luteinization in human periovulatory follicles.

Human reproduction (Oxford, England)·2023
Same author

Molecular changes in the equine follicle in relation to variations in antral follicle count and anti-Müllerian hormone concentrations.

Equine veterinary journal·2015
Same author

Hormonal regulation of tissue inhibitors of metalloproteinases during follicular development in the rat ovary.

Endocrine·2010
Same author

Endometriosis: in search of optimal treatment.

Minerva ginecologica·2010
Same author

American exceptionalism? Similarities and differences in national attitudes toward energy policy and global warming.

Environmental science & technology·2006
Same author

Expression of basigin, an inducer of matrix metalloproteinases, in the rat ovary.

Biology of reproduction·2005

RU 486, a progesterone antagonist, influences ovarian function, including folliculogenesis and ovulation. Early studies require careful interpretation due to potential extraovarian effects of RU 486.

Area of Science:

  • Reproductive Endocrinology
  • Molecular Pharmacology

Background:

  • RU 486 (mifepristone) is a key antiprogestin used to study progesterone's role in the ovary.
  • Early research using RU 486 necessitates considering potential extraovarian sites of action, such as the hypothalamic-pituitary axis and adrenal glands.

Purpose of the Study:

  • To critically evaluate the interpretation of RU 486's effects on ovarian function.
  • To highlight confounding factors in progesterone and RU 486 research, including extraovarian actions, receptor presence, dosage, and hormonal milieu.

Main Methods:

  • Review of experimental paradigms investigating RU 486's impact on ovarian physiology.
  • Analysis of factors influencing ovarian response to progesterone and its antagonists.

Main Results:

Related Experiment Videos

  • Systemic RU 486 administration can lead to indirect ovarian responses via extraovarian mechanisms.
  • Ovarian responses are influenced by the presence of progesterone receptors, dose of administered ligand, and hormonal context.
  • RU 486 regulates ovarian folliculogenesis, steroidogenesis, ovulation, and luteal function, supporting progesterone-dependent mechanisms.

Conclusions:

  • RU 486 is a valuable tool for understanding ovarian progesterone action, but its effects can be complex and indirect.
  • Careful consideration of experimental design and potential confounding factors is crucial for accurate interpretation of RU 486's ovarian effects.